39(top 2%)
papers
354(top 2%)
citations
9(top 2%)
h-index
18(top 2%)
g-index
44
all documents
410
doc citations
213
citing journals

Top Articles

#TitleJournalYearCitations
1Genetic Features of Late Onset Primary Hemophagocytic Lymphohistiocytosis in Adolescence or AdulthoodPLoS ONE201465
2Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myelomaOncogene202038
3Targeting NSD2-mediated SRC-3 liquid–liquid phase separation sensitizes bortezomib treatment in multiple myelomaNature Communications202137
4A multicenter, open‐label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myelomaAmerican Journal of Hematology201436
5<p>Progress in the identification of gene mutations involved in multiple myeloma</p>OncoTargets and Therapy201926
6Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 studyCancer Chemotherapy and Pharmacology201725
7Requirement for etoposide in the treatment of pregnancy related hemophagocytic lymphohistiocytosis: a multicenter retrospective studyOrphanet Journal of Rare Diseases201920
8Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myelomaChinese Journal of Cancer201619
9Myelomatous pleural effusion involvement in 23 patients with multiple myeloma: A single‐center clinical analysisThoracic Cancer201518
10Autologous stem cell transplant can overcome poor prognosis in patients with multiple myeloma with extramedullary plasmacytomaLeukemia and Lymphoma201411
11Immunoparesis recovery 1 year after ASCT is independently associated with favorable survival in patients with symptomatic multiple myeloma who undergo autologous stem cell transplantationAnnals of Hematology201910
12What Multiple Myeloma With t(11;14) Should Be Classified Into in Novel Agent Era: Standard or Intermediate Risk?Frontiers in Oncology202010
13Arsenic trioxide potentiates sensitivity of multiple myeloma cells to lenalidomide by upregulating cereblon expression levelsOncology Letters20179
14Human MutT homologue 1 mRNA overexpression correlates to poor response of multiple myelomaInternational Journal of Hematology20178
15A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple MyelomaAmerican Journal of Clinical Oncology: Cancer Clinical Trials20188
16Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple MyelomaBioMed Research International20187
17<p>Mutations In Thirty Hotspot Genes In Newly Diagnosed Chinese Multiple Myeloma Patients</p>OncoTargets and Therapy20197
18Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm studyBMC Medicine20227
19Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myelomaOncology Letters20156
20Fat fraction quantification of lumbar spine: comparison of T1-weighted two-point Dixon and single-voxel magnetic resonance spectroscopy in diagnosis of multiple myelomaDiagnostic and Interventional Radiology20206
21Novel Non-coding RNA Analysis in Multiple Myeloma Identified Through High-Throughput SequencingFrontiers in Genetics20216
22Genome-wide discovery and characterization of long noncoding RNAs in patients with multiple myelomaBMC Medical Genomics20195
23Mechanisms underlying synergism between circularized tumor necrosis factor‐related apoptosis inducing ligand and bortezomib in bortezomib‐sensitive or ‐resistant myeloma cellsHematological Oncology20224
24Significance of p85 expression as a prognostic factor for patients with breast cancerOncology Letters20143
25Targeted treatment of T-cell acute lymphoblastic leukemia: latest updates from the 2022 ASH Annual MeetingExperimental Hematology and Oncology20233
26Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis BChinese Medical Journal20162
27Autoantibodies against β1-adrenergic receptor: response to induction therapy with bortezomib-containing regimens for multiple myeloma patientsLeukemia and Lymphoma20182
28Clinical Characteristics and Risk Factors for Pleural Effusion in Patients with Multiple MyelomaInternational Journal of General Medicine20212
29Bone-Related Extramedullary Disease in Newly Diagnosed Myeloma Patients is an Independent Poor Prognostic PredictorClinical Medicine Insights: Oncology20222
30Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent eraCancer Medicine02
31Simultaneous occurrence of splenic diffuse large B cell lymphoma and gastrointestinal stromal tumor in the stomach: a case reportDiagnostic Pathology20181
32Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in ChinaCancer Biology and Medicine20211
33Autologous peripheral blood stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world studyChinese Medical Journal20211
34Detection of Circulating Plasma Cells in Multiple Myeloma with Extramedullary PlasmacytomaBlood20151
35Triplet RVd Induction for Transplant-Eligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-AnalysisAdvances in Therapy20221
36Chemotherapy with the use of next‐generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome–positive acute lymphoblastic leukemiaCancer20231
37T cell receptor rearrangements in a patient with γ-heavy chain disease: A case reportOncology Letters20160
38In vivo antitumor efficacy of 17-AAG loaded PMMA in a human multiple myeloma xenograft mouse modelClinical and Experimental Medicine20220
39Paraplegia secondary to disseminated mucormycosis: case report and literature reviewBMC Infectious Diseases20220
40Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantationBMC Cancer20220